skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,739  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: resource type: Text Resources remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Alkermes Plc Mural Oncology Call - Final
Material Type:
Text Resource
Add to My Research

Alkermes Plc Mural Oncology Call - Final

Fair Disclosure Wire, 2023

COPYRIGHT 2023 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

2
Apellis Pharmaceuticals Inc Corporate Call - Final
Material Type:
Text Resource
Add to My Research

Apellis Pharmaceuticals Inc Corporate Call - Final

Fair Disclosure Wire, 2022

COPYRIGHT 2022 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

3
Stoke Therapeutics Inc STK001 Call - Final
Material Type:
Text Resource
Add to My Research

Stoke Therapeutics Inc STK001 Call - Final

Fair Disclosure Wire, 2024

COPYRIGHT 2022 CQ-Roll Call, Inc. ;COPYRIGHT 2024 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

4
Myovant Sciences Ltd at SVB Leerink Global Healthcare (Virtual) - Final
Material Type:
Text Resource
Add to My Research

Myovant Sciences Ltd at SVB Leerink Global Healthcare (Virtual) - Final

Fair Disclosure Wire, 2022

COPYRIGHT 2022 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

5
Jazz Pharmaceuticals PLC Zanidatamab KOL - Final
Material Type:
Text Resource
Add to My Research

Jazz Pharmaceuticals PLC Zanidatamab KOL - Final

Fair Disclosure Wire, 2023

COPYRIGHT 2023 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

6
Taysha Gene Therapies Inc To Discuss CLN7 Program Acquisition Call - Final
Material Type:
Text Resource
Add to My Research

Taysha Gene Therapies Inc To Discuss CLN7 Program Acquisition Call - Final

Fair Disclosure Wire, 2021

COPYRIGHT 2021 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

7
Denali Therapeutics Inc to Present Phase 1/2 Study of DNL310 Presentation - Final
Material Type:
Text Resource
Add to My Research

Denali Therapeutics Inc to Present Phase 1/2 Study of DNL310 Presentation - Final

Fair Disclosure Wire, 2021

COPYRIGHT 2021 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

8
Ionis Pharmaceuticals Inc Olezarzen Balance Study Data Webcast - Final
Material Type:
Text Resource
Add to My Research

Ionis Pharmaceuticals Inc Olezarzen Balance Study Data Webcast - Final

Fair Disclosure Wire, 2024

COPYRIGHT 2024 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

9
Event Brief of Sarepta Therapeutics Inc at Leerink Partners Global Biopharma Conference - Final
Material Type:
Text Resource
Add to My Research

Event Brief of Sarepta Therapeutics Inc at Leerink Partners Global Biopharma Conference - Final

Fair Disclosure Wire, 2024

COPYRIGHT 2024 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

10
Capricor Therapeutics Inc to Host Key Opinion Leader (KOL) Call on CAP1002 - Final
Material Type:
Text Resource
Add to My Research

Capricor Therapeutics Inc to Host Key Opinion Leader (KOL) Call on CAP1002 - Final

Fair Disclosure Wire, 2020

COPYRIGHT 2020 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

11
Event Brief of Ionis Pharmaceuticals Inc Corporate Update - Final
Material Type:
Text Resource
Add to My Research

Event Brief of Ionis Pharmaceuticals Inc Corporate Update - Final

Fair Disclosure Wire, 2023

COPYRIGHT 2023 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

12
Stoke Therapeutics Inc To Present Interim Data From MONARCH Study In Dravet Syndrome Interim Analysis Call - Final
Material Type:
Text Resource
Add to My Research

Stoke Therapeutics Inc To Present Interim Data From MONARCH Study In Dravet Syndrome Interim Analysis Call - Final

Fair Disclosure Wire, 2021

COPYRIGHT 2021 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

13
Allovir Inc Discussion on the Potential Clinical Impact of Posoleucel for the Treatment of BK Viremia in Kidney Transplant Patients Corporate Call - Final
Material Type:
Text Resource
Add to My Research

Allovir Inc Discussion on the Potential Clinical Impact of Posoleucel for the Treatment of BK Viremia in Kidney Transplant Patients Corporate Call - Final

Fair Disclosure Wire, 2023

COPYRIGHT 2023 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

14
Prothena Corporation PLC to Discuss AFFIRMAL Study Conference Call - Final
Material Type:
Text Resource
Add to My Research

Prothena Corporation PLC to Discuss AFFIRMAL Study Conference Call - Final

Fair Disclosure Wire, 2021

COPYRIGHT 2021 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

15
Ocugen Inc at Noble Financial Small Microcap Investor Conference (Virtual) - Final
Material Type:
Text Resource
Add to My Research

Ocugen Inc at Noble Financial Small Microcap Investor Conference (Virtual) - Final

Fair Disclosure Wire, 2021

COPYRIGHT 2021 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

16
United Therapeutics Corp at Leerink Partners Global Biopharma Conference - Final
Material Type:
Text Resource
Add to My Research

United Therapeutics Corp at Leerink Partners Global Biopharma Conference - Final

Fair Disclosure Wire, 2024

COPYRIGHT 2024 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

17
Sarepta Therapeutics Inc at Leerink Partners Global Biopharma Conference - Final
Material Type:
Text Resource
Add to My Research

Sarepta Therapeutics Inc at Leerink Partners Global Biopharma Conference - Final

Fair Disclosure Wire, 2024

COPYRIGHT 2024 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

18
Apellis Pharmaceuticals Inc DERBY and OAKS 18 Month Data Conference Call - Final
Material Type:
Text Resource
Add to My Research

Apellis Pharmaceuticals Inc DERBY and OAKS 18 Month Data Conference Call - Final

Fair Disclosure Wire, 2022

COPYRIGHT 2022 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

19
BridgeBio Pharma Inc to Discuss Additional Data from the Phase 3 ATTRibuteCM Study - Final
Material Type:
Text Resource
Add to My Research

BridgeBio Pharma Inc to Discuss Additional Data from the Phase 3 ATTRibuteCM Study - Final

Fair Disclosure Wire, 2023

COPYRIGHT 2023 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

20
Biomarin Pharmaceutical Inc at SVB Leerink Global Healthcare (Virtual) - Final
Material Type:
Text Resource
Add to My Research

Biomarin Pharmaceutical Inc at SVB Leerink Global Healthcare (Virtual) - Final

Fair Disclosure Wire, 2022

COPYRIGHT 2022 CQ-Roll Call, Inc.

Digital Resources/Online E-Resources

Results 1 - 20 of 1,739  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1997  (14)
  2. 1997 To 2002  (162)
  3. 2003 To 2008  (206)
  4. 2009 To 2015  (1,189)
  5. After 2015  (455)
  6. More options open sub menu

Searching Remote Databases, Please Wait